Safety and efficacy of formoterol delivered via a novel DPI device in children with asthma
K. Papataxiarchou, V. Aivazis, E. Paraschakis, P. Panagiotopoulou, L. Tsartsali, N. Grekas, O. Porichi, C. Iskos, K. Athanassiou (Pikermi, Thessaloniki, Alexandroupolis, Athens, Greece)
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Session: Paediatric asthma, rhinitis and management
Session type: E-Communication Session
Number: 5630
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Papataxiarchou, V. Aivazis, E. Paraschakis, P. Panagiotopoulou, L. Tsartsali, N. Grekas, O. Porichi, C. Iskos, K. Athanassiou (Pikermi, Thessaloniki, Alexandroupolis, Athens, Greece). Safety and efficacy of formoterol delivered via a novel DPI device in children with asthma. Eur Respir J 2010; 36: Suppl. 54, 5630
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Device preference and efficacy of formoterol aerolizer and salbutamol MDI in children with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 134s Year: 2003
Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002
Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020
Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002
Comparative efficacy and costs of the treatment of moderate to severe persistent asthma with a new dry-powder inhaled beclomethasone dipropionate and formoterol combination Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
Efficacy and safety of the new beclomethasone dipropionate/formoterol combination (HFA MDI) vs. budesonide/formoterol (DPI) in moderate to severe persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Efficacy of combined budesonide/formoterol delivered via turbuhaler on lung function and asthma control in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 496s Year: 2003
Efficacy of salmeterol/fluticasone pMDI versus DPI in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006
Formoterol provides comparable bronchoprotection when delivered via DPI and MDI devices in mild-moderate asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 311s Year: 2004
Safety and tolerability of high-dose formoterol via aerolizer and salbutamol via MDI in patients with mild-to-moderate COPD Source: Eur Respir J 2003; 22: Suppl. 45, 285s Year: 2003
Safety of formoterol in asthma trials Source: Eur Respir J 2007; 30: Suppl. 51, 248s Year: 2007
The efficacy and safety formoterol-HFA pMDI in school children with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 460s Year: 2007
Safety of formoterol by Turbuhaler(R) as reliever medication compared with terbutaline in moderate asthma Source: Eur Respir J 2002; 20: 859-866 Year: 2002
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial Source: Eur Respir J 2003; 22: 787-794 Year: 2003
Safety of as-needed formoterol in asthma patients on different maintenance long-acting ß2-agonists Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
Comparison of bronchodilator effect of salbutamol delivered via MDI + spacer and DPI in children with asthma Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Treatment of acute severe asthma with formoterol Turbuhaler provides a similar effect on patients' well-being as salbutamol by pMDI plus spacer Source: Eur Respir J 2002; 20: Suppl. 38, 47s Year: 2002
Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008